Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%
recruiting125%
unknown250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

NCT05000827
completednot_applicable

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

NCT04790968
unknownnot_applicable

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

NCT05161728
unknownnot_applicable

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

NCT03134261

Clinical Trials (4)

Showing 4 of 4 trials
NCT05000827Not Applicable

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Recruiting
NCT04790968Not Applicable

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Completed
NCT05161728Not Applicable

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Unknown
NCT03134261Not Applicable

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4